Validation of a 3 day electronic bladder diary as an app for smart‐phone
Autor: | Luis López-Fando, Antonio Alcaraz, Laura Mateu Arrom, Agustín Franco de Castro, Lluís Peri Cusi, Miguel Ángel Jiménez Cidre |
---|---|
Rok vydání: | 2019 |
Předmět: |
Adult
Male medicine.medical_specialty Smart phone Urology 030232 urology & nephrology Young Adult 03 medical and health sciences 0302 clinical medicine McNemar's test Surveys and Questionnaires Humans Medicine Nocturia Prospective Studies Prospective cohort study Aged Aged 80 and over 030219 obstetrics & reproductive medicine Urinary Bladder Overactive business.industry Reproducibility of Results Middle Aged Mobile Applications Overactive bladder syndrome humanities Test (assessment) Cross-Sectional Studies Convergent validity Physical therapy Female Neurology (clinical) Bladder diary medicine.symptom business |
Zdroj: | Neurourology and Urodynamics. 38:764-769 |
ISSN: | 1520-6777 0733-2467 |
DOI: | 10.1002/nau.23914 |
Popis: | AIM To validate an electronic 3-day bladder diary (BD) as an easy-to-use app for smart-phone (eDM3d). METHODS Descriptive and cross-sectional prospective study. One hundred and thirty-six patients with overactive bladder syndrome (OABs) or nocturia who had a smart-phone and attended the urology clinics of a tertiary hospital from June to November 2017 were included. Patients filled the eDM3d (test) and the Spanish validated paper BD (DM3d) and questionnaires ICIQ-UISF and BASQ during the first week. Two weeks later, they repeated the eDM3d (retest). We assessed feasibility of the eDM3d (percentage of variables completed), test-retest reliability (qualitative variables: McNemar test; quantitative variables: ICC), paper-app correlation (qualitative variables: Kappa index; quantitative variables: ICC) and convergent validity (correlation between eDM3d and questionnaires, Spearman's rank test). Patients answered a question about satisfaction: "If you had to repeat a BD again, would you choose paper or the app version?" RESULTS One hundred and twenty-three (90.4%) participants completed all the variables of the first eDM3d. There were no significant differences in the proportion of patients classified as positive for each symptom between test and retest. ICC ranged from 0.73 to 0.94 for all variables (P |
Databáze: | OpenAIRE |
Externí odkaz: |